Semaglutide
+ Vitamin B12
Semaglutide
+ Vitamin B12
Clinician-led GLP-1 weight loss.
5-minute online assessment · No obligation
Compounded medications, while permitted under federal law, are not approved by the FDA. The FDA does not review these medications for safety or efficacy. Important safety information. Membership Requirement: All treatment options require a weight loss membership focused on clinical care and support.
When your body starts working with you
The constant noise fades. Hunger becomes manageable.
You eat with intention — not impulse.
Your biology shifts first. Willpower stops doing all the work.
With appetite regulated, progress begins — steadily, noticeably.
The scale finally reflects the effort you've been making.
This isn't a spike. It's traction.
Because the change starts with appetite, results are easier to maintain.
Not a reset. Not a rebound. Just forward.
This is the difference between losing weight and keeping it off.
The constant noise fades. Hunger becomes manageable.
You eat with intention — not impulse.
Your biology shifts first. Willpower stops doing all the work.
With appetite regulated, progress begins — steadily, noticeably.
The scale finally reflects the effort you've been making.
This isn't a spike. It's traction.
Because the change starts with appetite, results are easier to maintain.
Not a reset. Not a rebound. Just forward.
This is the difference between losing weight and keeping it off.
Real progress. Real people.
How it works
Start My Treatment
Complete the intake form
Answer a few questions about your health history, goals, and what you've tried before.
Medical provider review
A licensed provider will review your information and recommend a personalized treatment plan, if appropriate.
Free discreet shipping
If prescribed, your medication ships free directly to your door in discreet packaging.
FAQ: Compounded Semaglutide (GLP-1 Weight Loss)
New England Journal Of Medicine
*In a 68-week placebo-controlled study of 1,961 obese and overweight non-diabetic adults with weight-related conditions, those on semaglutide lost on average 14.9% of their weight as opposed to 2% of the placebo group. Both groups followed a reduced-calorie diet, increased physical activity, and monthly nutritional counseling. Starting semaglutide (Wegovy®) dosage was 0.25mg per week, increasing to 2.4mg. The trial was overseen and sponsored by Novo Nordisk.
While facilities making compounded medications are strictly regulated for certain quality practices, the compounded medications themselves are not approved or evaluated by the FDA for safety, effectiveness, or quality.
Always discuss potential side effects with a healthcare provider.
For compounded tirzepatide:
Monthly: $299 per month (billed separately)
For compounded tirzepatide microdoses:
Monthly: $199 per month (billed separately)
For compounded semaglutide:
Monthly: $299 per month (billed separately)
Other medications, such as Metformin ($90/ 3 months), Ozempic® ($1,199/month) and Wegovy® ($1,599/month), are also billed separately and are not included in the membership plans.
Zepbound single-dose vials are offered via LillyDirect and are available as a cash pay-only offering starting at $299/mo for the 2.5 mg dose. LillyDirect has the ability to change the price. Unlike our other weight loss medication options we offer, Zepbound single-dose vials are delivered, charged, and managed separately via LillyDirect.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Novo Nordisk is a registered trademark of Novo Nordisk A/S. Zepbound™ is a registered trademark of Eli Lilly and Company.
Your clinician-led telehealth platform.
Chosen by clinicians. Trusted by patients.
Care decisions are led by board-certified clinicians, with every prescription reviewed by a licensed provider in your state.
